AKF-D52, a Synthetic Phenoxypyrimidine-Urea Derivative, Triggers Extrinsic/Intrinsic Apoptosis and Cytoprotective Autophagy in Human Non-Small Cell Lung Cancer Cells

QR Code

AKF-D52, a Synthetic Phenoxypyrimidine-Urea Derivative, Triggers Extrinsic/Intrinsic Apoptosis and Cytoprotective Autophagy in Human Non-Small Cell Lung Cancer Cells

Previously, we discovered that 1-(3,5-dimethoxyphenyl)-3-(4-(3-methoxyphenoxy)-2-((4-morpholinophenyl)amino)pyrimidin-5-yl)urea (AKF-D52), a synthetic phenoxypyrimidine urea derivative, acts as a growth inhibitor of various cancer cell types. In this study, we elucidated the antiproliferative proper...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Hyo-Sun Gil, Jeong-Hun Lee, Ahmed K. Farag, Ahmed H. E. Hassan, Kyung-Sook Chung, Jung-Hye Choi, Eun-Joo Roh, Kyung-Tae Lee
Format:	article
Langue:	EN
Publié:	MDPI AG 2021
Sujets:	AKF-D52 non-small cell lung cancer (NSCLC) apoptosis autophagy reactive oxygen species (ROS) Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/f52f7ce6b4b14e9ca8f82f05b51cd34c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients
par: Mehta A, et autres
Publié: (2020)

Clipper 5.2 Avanzado
par: Ramalho, José A.
Publié: (1994)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
par: Giustini N, et autres
Publié: (2021)

Clinical utility of ramucirumab in non-small-cell lung cancer
par: Uprety D
Publié: (2019)

RAD52: Paradigm of Synthetic Lethality and New Developments
par: Matthew J. Rossi, et autres
Publié: (2021)

Origin of the Functional Distinctiveness of NF-κB/p52
par: Gourisankar Ghosh, et autres
Publié: (2021)

Role of afatinib in the treatment of advanced lung squamous cell carcinoma
par: Vavalà T
Publié: (2017)

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer
par: Weinberg F, et autres
Publié: (2019)

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
par: Veldore VH, et autres
Publié: (2018)

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis
par: Meng Yuan, et autres
Publié: (2021)

Vitamin D Supplementation Improves Uterine Receptivity in a Rat Model of Vitamin D Deficiency: A Possible Role of HOXA-10/FKBP52 Axis
par: Hend Ashour, et autres
Publié: (2021)

Identification and Validation of an Immune and Ferroptosis-Combined Index for Non–Small Cell Lung Cancer
par: Yang Teng, et autres
Publié: (2021)

Small cell lung cancer transformation during antitumor therapies: A systematic review
par: Chai Xing, et autres
Publié: (2021)

Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma
par: Emma Polonio-Alcalá, et autres
Publié: (2021)

A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
par: Alessio Bruni, et autres
Publié: (2021)

The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
par: Jian Wang, et autres
Publié: (2021)

Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
par: Alessio Bruni, et autres
Publié: (2021)

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
par: Schuette W, et autres
Publié: (2017)

Regulation of ROS-Dependent JNK Pathway by 2’-Hydroxycinnamaldehyde Inducing Apoptosis in Human Promyelocytic HL-60 Leukemia Cells
par: Kyung-Sook Chung, et autres
Publié: (2021)

MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer
par: Hongli Pan, et autres
Publié: (2021)

Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production
par: Martínez-Torres AC, et autres
Publié: (2018)

Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth
par: Peng-Fei Jiao, et autres
Publié: (2021)

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
par: He Ba, et autres
Publié: (2021)

Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity
par: Cobo M, et autres
Publié: (2017)

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer
par: Barrows SM, et autres
Publié: (2019)

Sicca syndrome in the same family – the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren’s syndrome
par: Arkadiusz Koszarny, et autres
Publié: (2021)

Association of expression and genotypes of thymidylate synthase in non-small cell lung cancer patients with different clinicopathological characteristics
par: Chen Jin-Yin, et autres
Publié: (2021)

Severe hyponatremia due to paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in non-small cell lung carcinoma transforming to small cell lung carcinoma during treatment with immune checkpoint inhibitor
par: Vicky Mai, et autres
Publié: (2021)

Targeting MERTK and AXL in <i>EGFR</i> Mutant Non-Small Cell Lung Cancer
par: Dan Yan, et autres
Publié: (2021)

Small cell transformation in crizotinib‐resistant ROS1‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report
par: Chi‐Hao Wu, et autres
Publié: (2021)

An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized gold nanoparticles using Cardiospermum halicacabum on AGS gastric carcinoma cells
par: Li C, et autres
Publié: (2019)

La sociología en Chile : instituciones y practicantes /
par: Barrios, Alicia, 1955-
Publié: (1988)

LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP [Expression of Concern]
par: Gong Z, et autres
Publié: (2021)

New targeted treatments for non-small-cell lung cancer – role of nivolumab
par: Zago G, et autres
Publié: (2016)

miRNA-21 as a novel therapeutic target in lung cancer
par: Markou A, et autres
Publié: (2016)

Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non‐small cell lung cancer patients
par: Hang Li, et autres
Publié: (2021)

Glioma Cells Acquire Stem-like Characters by Extrinsic Ribosome Stimuli
par: Yuki Shirakawa, et autres
Publié: (2021)

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
par: Garcia-Valdecasas Gayo Sonsoles, et autres
Publié: (2020)

Efficacy of radiosensitizing doped titania nanoparticles under hypoxia and preparation of an embolic microparticle
par: Morrison RA, et autres
Publié: (2017)

<sup>1</sup>H HR-MAS NMR Based Metabolic Profiling of Lung Cancer Cells with Induced and De-Induced Cisplatin Resistance to Reveal Metabolic Resistance Adaptations
par: Martina Vermathen, et autres
Publié: (2021)